Non Exudative AMD Imaged With SS-OCT- Extension

STATUS

Recruiting
participants needed

450
sponsor

Boston Image Reading Center

Send

Updated on 19 February 2024

See if I qualify

age-related macular degeneration

retinal pigment

drug trials

macular degeneration

maculopathy

Summary

The investigators wish to better understand the role of the choriocapillaris (CC) in the formation and progression of non-exudative in age related macular degeneration (armd) by imaging the retinal pigment epithelium (rpe) and the choroidal microvasculature and by studying their inter-dependence to determine if the loss of the CC could prove useful as an anatomic clinical trial endpoint in future drug trials.

Description

Details

Condition	Dry Macular Degeneration, age-related macular degeneration, macular degeneration, macular degeneration
Age	100years or below
Treatment	SS-OCT imaging
Clinical Study Identifier	NCT04469140
Sponsor	Boston Image Reading Center
Last Modified on	19 February 2024

How understandable was the trial content above?

Hard to understand

Easy to understand

Eligibility		Yes	No	Not Sure
Inclusion Criteria
	Enrollment in and completion of the BIRC-01 study
	Clinic diagnosis of non-exudative iAMD in at least one eye with a drusen volume in the central 3 mm circle centered on the fovea of at least 0.02 mm3 in the absence of GA or nGA as diagnosed with OCT en face imaging OR Clinical diagnosis of early or early/intermediate stage AMD in one eye in the absence of nGA or GA and exudative AMD in the other eye OR clinical diagnosis of GA or nGA secondary to AMD that is at least the size of a large druse (125 microns in diameter; 0.05 mm2) and no greater than 7 disc areas (17 mm2) in at least one eye which has never been treated with anti-VEGF agents
	Willing and able to comply with clinic visits and study-related procedures
	Provide signed informed consent
Exclusion Criteria
	Subjects with exudative AMD in both eyes
	Eyes with evidence of non-proliferative and proliferative diabetic retinopathy
	Presence of confounding ocular diagnosis such as myopia >6D, or other ocular conditions that may cause retinal pigment epithelium atrophy or exudative MNV
	Subjects currently or previously enrolled in other interventional clinical trials in which treatment was administered to the study eye
	Previous vitrectomy or intravitreal injections in the study eye
	Axial length measurement 26 mm
	Subjects unable to give informed consent
	Subjects who are unable to comply with imaging guidelines

How to participate?

Step 1 Connect with a study center

Send a message

Enter your contact details to connect with study team

First name*

Last name*

Email*

Phone number*

Other language

I am at least 18 years old.

By sending a message, I agree to share my information with the study team for the selected site and consent to receive emails and text messages for trial updates, notifications, and related communication. TrialX values your privacy; your information will be handled in accordance with our Privacy Policy

Step 2 Get screened

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

Step 3 Enroll in the clinical study

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Step 4 Get your study results

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Browse trials for

age-related macular degeneration

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Non Exudative AMD Imaged With SS-OCT- Extension